$0.5241
0.024.82%
Pre-Market: Dec 20, 7:50 PM EDT
Comments
Loading...
Bolt Biotherapeutics (BOLT) Forecast
NewsEarningsBolt Biotherapeutics (BOLT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBolt Biotherapeutics (NASDAQ:BOLT) Stock Quotes, Forecast and News Summary
Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bolt Biotherapeutics (BOLT) stock?
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Who are Bolt Biotherapeutics (BOLT) competitors?
Other companies in Bolt Biotherapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), CARISMA Therapeutics (NASDAQ:CARM), Nanoviricides (AMEX:NNVC), Palatin Techs (AMEX:PTN) and Geovax Labs (NASDAQ:GOVX).
What is the forecast, or price target, for Bolt Biotherapeutics (BOLT) stock?
Bolt Biotherapeutics has a consensus price target of $2.38.
What is the current price for Bolt Biotherapeutics (BOLT)?
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.5241 last updated December 20, 2024 at 7:50 PM EST.
Does Bolt Biotherapeutics (BOLT) pay a dividend?
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
When is Bolt Biotherapeutics (NASDAQ:BOLT) reporting earnings?
Bolt Biotherapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Bolt Biotherapeutics (BOLT) going to split?
There is no upcoming split for Bolt Biotherapeutics.
What sector and industry does Bolt Biotherapeutics (BOLT) operate in?
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.